SAM
ENTA icon

Smartleaf Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Smartleaf Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67K Hold
184
– – ﹤0.01% 2875
2026
Q1 		$2.24K Sell
184
-226
-55% -$3.03K ﹤0.01% 2929
2025
Q4 		$6.52K Hold
410
– – ﹤0.01% 2595
2025
Q3 		$6.21K Buy
410
+339
+477% +$2.71K ﹤0.01% 2302
2025
Q2 		$532 Sell
71
-363
-84% -$2.18K ﹤0.01% 2575
2025
Q1 		$2.48K Buy
+434
New +$2.68K ﹤0.01% 2415
2024
Q4 		– Sell
-157
Closed -$1.58K – 2950
2024
Q3 		$1.58K Buy
+157
New +$2.05K ﹤0.01% 2554

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Smartleaf Asset Management's ENTA Position: Q2 2026 in Review

Smartleaf Asset Management held its Enanta Pharmaceuticals (ENTA) position steady in Q2 2026 at 184 shares worth $2.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2875.

Smartleaf Asset Management first reported a position in ENTA in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.52K in Q4 2025. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Smartleaf Asset Management held 184 shares of Enanta Pharmaceuticals worth $2.67K as of Q2 2026.
  • Smartleaf Asset Management left its Enanta Pharmaceuticals share count unchanged in Q2 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2875 holding.
  • Smartleaf Asset Management first reported a position in Enanta Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Smartleaf Asset Management's Enanta Pharmaceuticals position peaked at $6.52K in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.